Literature DB >> 18868825

Congenital impatency of the nasolacrimal duct.

D GUERRY, E L KENDIG.   

Abstract

Entities:  

Keywords:  LACRIMAL ORGANS/duct impatent

Mesh：

Year:  1948        PMID： 18868825     DOI： 10.1001/archopht.1948.00900020198006

Source DB:  PubMed          Journal:  Arch Ophthal


× No keyword cloud information.
  20 in total

1.  Paediatric powered endonasal dacryocystorhinostomy.

Authors:  Dania Al-Nuaimi; Clare Inkster; Christopher Lobo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-26       Impact factor: 2.503

Review 2.  Probing for congenital nasolacrimal duct obstruction.

Authors:  Carisa Petris; Don Liu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

3.  Office probing for treatment of nasolacrimal duct obstruction in infants.

Authors:  Aaron M Miller; Danielle L Chandler; Michael X Repka; Darren L Hoover; Katherine A Lee; Michele Melia; Paul J Rychwalski; David I Silbert; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Graham E Quinn; Nick A Sala; Susan Schloff; David K Wallace; Nicole C Foster; Kevin D Frick; Richard P Golden; Scott R Lambert; D Robbins Tien; David R Weakley
Journal:  J AAPOS       Date:  2014-02       Impact factor: 1.220

4.  [Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].

Authors:  J Heichel; F Bachner; A Schmidt-Pokrzywniak; H-G Struck; U Stuhlträger; T Bredehorn-Mayr
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

5.  Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.

Authors:  Deok Sun Cha; Hwa Lee; Min Soo Park; Jong Mi Lee; Se Hyun Baek
Journal:  Korean J Ophthalmol       Date:  2010-10-05

Review 6.  [Congenital nasolacrimal duct obstruction from an ophthalmologist's point of view : Causes, diagnosis and staged therapeutic concept].

Authors:  J Heichel; T Bredehorn-Mayr; H-G Struck
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

7.  Lacrimal and nasal masquerades of congenital nasolacrimal duct obstructions: etiology, management, and outcomes.

Authors:  Saurabh Kamal; Mohammad Javed Ali; Adit Gupta; Milind N Naik
Journal:  Int Ophthalmol       Date:  2015-02-14       Impact factor: 2.031

8.  A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-12

9.  Acquired nasolacrimal duct obstruction in children.

Authors:  Kyu Mee Kay; Kyung In Woo; Jung Hoon Kim; Hae Ran Chang
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

10.  Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.

Authors:  Igal Leibovitch; Dinesh Selva; Angelo Tsirbas; Edward Greenrod; John Pater; Peter J Wormald
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.